Zobrazeno 1 - 10
of 904
pro vyhledávání: '"M. Aguas"'
Autor:
M Baldan-Martin, M Azkargorta, I Lloro, I Soleto Fernández, M Orejudo, C Ramírez, S García, J Mercado, S Riestra, M Rivero, A Gutiérrez, I Rodríguez-Lago, L Fernández-Salazar, D Ceballos, J M Benítez, M Aguas, I Bastón-Rey, F Bermejo, M J Casanova, R Lorente, Y Ber, V Royo, M Esteve, F Elortza, J P Gisbert, M Chaparro
Publikováno v:
Journal of Crohn's and Colitis. 17:i268-i271
Background Inflammatory bowel diseases (IBD) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e323bc39c240e3927d99b4b88bfb294
https://doi.org/10.1093/ecco-jcc/jjac190.0236
https://doi.org/10.1093/ecco-jcc/jjac190.0236
Autor:
I Soleto, M Baldan, C Ramírez, M Orejudo, S García, J Mercado, M Azkargorta, I Lloro, L Ortega Moreno, L Aldars Garcia, S Riestra, M Rivero, A Gutiérrez, I Rodríguez-Lago, L Fernández, D Ceballos, J M Benítez, M Aguas, I Bastón Rey, F Bermejo, M J Casanova, R Lorente, Y Ber, D Ginard, M Esteve, F Elortza, J P Gisbert, N Martin-Cofreces, M Chaparro
Publikováno v:
Journal of Crohn's and Colitis. 17:i217-i219
Background The etiology and pathogenesis of inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) are complex and the mechanisms that lead to the development of these diseases remain unclear. Extracellular vesicles (EVs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04984c1e012a0dc8e4f385d2829ccc7d
https://doi.org/10.1093/ecco-jcc/jjac190.0179
https://doi.org/10.1093/ecco-jcc/jjac190.0179
Autor:
M Aguas Peris, J Del Hoyo, R Vicente, M Barreiro-de Acosta, L Melcarne, A Hernández-Camba, E Alfambra, L Madero, B Sicilia, M Chaparro, M D Martín-Arranz, R Pajares, F Mesonero, M Mañosa, P Martínez, S Chacón, J Tosca, S Marín, L Sanromán, M Calvo, D Monfort, E Saiz, Y Zabana, I Guerra, P Varela, R Faubel, P Corsino, S Porto-Silva, E Brunet, A Gutiérrez, P Nos
Publikováno v:
Journal of Crohn's and Colitis. 17:i35-i37
Background Telemedicine is not consistently superior to standard care in the management of inflammatory bowel disease (IBD). Non-inferiority is an acceptable outcome if telemedicine improves the efficacy and efficiency of care. Owing to the positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9b6c6b46b41ff151bc3e8c23a874d0
https://doi.org/10.1093/ecco-jcc/jjac190.0026
https://doi.org/10.1093/ecco-jcc/jjac190.0026
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
02.01 - Acute critical care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fccb62d12bb854581c7cceef9d6a974e
https://doi.org/10.1183/13993003.congress-2022.3
https://doi.org/10.1183/13993003.congress-2022.3
Autor:
M Chaparro, M Aguas, M Livne, P Rivière, A Bar-Gil Shitrit, P Myrelid, M Arroyo, M Barreiro-de Acosta, M Bautista, L Biancone, I A Biron, T Boysen, D Carpio, B Castro, G Dragoni, P Ellul, S D Holubar, M Á de Jorge, E Leo, N Manceñido, A Moens, P Ramírez de la Piscina, P Ricanek, L Sebkona, L Sempere, N Teich, J P Gisbert, M Julsgaard
Publikováno v:
Journal of Crohn's and Colitis. 16:i452-i454
Background Data on the outcomes of surgery due to IBD in pregnant patients is scarce, and primarily dates back more than 3 decades ago. Primary aim: to evaluate the evolution of pregnancies and offspring after surgery due to IBD. Secondary aims: to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763d812670a865594a8ff10692b7c810
https://doi.org/10.1093/ecco-jcc/jjab232.614
https://doi.org/10.1093/ecco-jcc/jjab232.614
Autor:
M Chaparro, A Gutiérrez, C Calviño-Suárez, J M Huguet, M Calvo, M Aguas, R Camargo Camero, M Á de Jorge Turrión, D Hervías Cruz, P López Serrano, S Marín Pedrosa, P Martínez Montiel, M Rivero, R Vicente Lidón, L Arias García, M Arroyo, L Bujanda, M J Casanova, M Figueiras, A J Lucendo, N Manceñido Marcos, L Márquez, M D Martín-Arranz, M Boscá Watts, Y Ber, P Ramírez de la Piscina Urraca, I Pérez-Martínez, V Robles, A Ruiz-Cerulla, J M Vázquez Morón, L Madero, M Barreiro-de Acosta, M Capilla, I Vera Mendoza, D Acosta, Y Brenes, S Hermida, P Parra, M G Donday, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 16:i491-i493
Background The safety of ustekinumab in pregnant patients with inflammatory bowel disease (IBD) and in their offspring has been barely studied. Aims Primary: To know the risk of serious adverse events (SAEs) in women exposed to ustekinumab during pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::937c68b486a568e6c69c84324094d726
https://doi.org/10.1093/ecco-jcc/jjab232.672
https://doi.org/10.1093/ecco-jcc/jjab232.672
Autor:
M J García, S Riestra, A Amiot, M Julsgaard, I García de la Filia, M Calafat, M Aguas, L de la Peña, C Roig-Ramos, B Caballol, M J Casanova, K Farkas, T Boysen, L Bujanda, C Cuarán, D Dobru, F Fousekis, C J Gargallo-Puyuelo, E Savarino, X Calvet, J M Huguet, L Kupcinskas, J López-Cardona, T Raine, J van Oostrom, J P Gisbert, M Chaparro
Publikováno v:
Journal of Crohn's and Colitis. 17:i911-i912
Background The advent of new therapeutic agents and the improvement of supporting care might change the management of acute severe ulcerative colitis (ASUC) to avoid colectomy and change the natural history of the disease. The effectiveness and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea6388062755280b09e465a7e8821f57
https://doi.org/10.1093/ecco-jcc/jjac190.0908
https://doi.org/10.1093/ecco-jcc/jjac190.0908
Autor:
M I Iborra Colomino, R Ferreiro-Iglesias, M D Martín-Arranz, F Mesonero-Gismero, A Mínguez, S Porto Silva, L García-Ramírez, I García de la Filia, G Bastida, L Nieto García, C Suárez Ferrer, M Aguas, M Barreiro de Acosta, P Nos
Publikováno v:
Journal of Crohn's and Colitis. 17:i629-i630
Background Ustekinumab has been recently approved for the treatment of moderately to severe ulcerative colitis (UC). Data from the UNIFI clinical trial are encouraging; nevertheless, real-world assessment is needed. We assess the effectiveness, safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ddcb8c8da0d112c6a6f9fc91c90147
https://doi.org/10.1093/ecco-jcc/jjac190.0630
https://doi.org/10.1093/ecco-jcc/jjac190.0630
Autor:
L Madero Velázquez, V Jovani, M Andrés, P Más, M Aguas, E Vicens, A Ojeda, J R Noguera-Pons, L Ranieri, Y Zabana, M Pujol, M Barreiro de Acosta, E Pérez-Pampin, L Bernal, O Belen, V Moreno, M F García, L Sempere, P Zapater, A Gutiérrez Casbas
Publikováno v:
Journal of Crohn's and Colitis. 17:i553-i554
Background Inflammatory arthropathies are the most common EIM associated to IBD with a prevalence of 20-50% for axial inflammation and 5-20% for peripheral arthritis. AntiTNF is the preferred treatment in patients with axial spondiloarthritis (AxSp)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6794036a44f4c7c74751683cb5e19fdd
https://doi.org/10.1093/ecco-jcc/jjac190.0554
https://doi.org/10.1093/ecco-jcc/jjac190.0554